Sienna Ultimate Wireless Amplifier
Device Facts
| Record ID | K171397 |
|---|---|
| Device Name | Sienna Ultimate Wireless Amplifier |
| Applicant | Ems Handels Gesellschaft M.B.H. |
| Product Code | GWL · Neurology |
| Decision Date | Oct 6, 2017 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 882.1835 |
| Device Class | Class 2 |
Indications for Use
The Sienna Ultimate EEG amplifier is intended to be used as a front end amplifier to acquire, store and transmit electrophysiological signals in a wired or wireless mode for the EMS Neurodiagnostic system.
Device Story
Portable EEG amplifier; acquires electrophysiological signals via EEG electrodes/headcaps; optional SpO2 monitoring via external sensors. Operates in wired (isolated LAN) or wireless (WLAN) modes; stores data locally on 32GB flash card for backup/transmission when out of range. Used by trained healthcare professionals in clinics, hospitals, ORs, and epilepsy centers. Provides signal acquisition for neurodiagnostic systems; output viewed by clinicians via Sienna EEG software to support diagnostic decision-making. Benefits include portable, flexible EEG monitoring with high input impedance for signal quality.
Clinical Evidence
Bench testing only. No clinical data. Device passed testing for basic safety (IEC 60601-1), EMC (IEC 60601-1-2), usability (IEC 60601-1-6), and particular requirements for electroencephalographs (IEC 60601-2-26). Risk management conducted per ISO 14971. Radio spectrum and SAR compliance verified per FCC and EN standards. Battery safety verified per UN/DOT 38.3.
Technological Characteristics
Portable 32/64-channel EEG amplifier; 16-bit SAR ADC; input impedance >100 MΩ; CMRR >110dB; bandwidth 0.1-1500 Hz. Connectivity: Ethernet or 802.11b/g wireless. Power: Li-ion battery or medical-grade supply. Storage: 32GB flash. Standards: IEC 60601-1, IEC 60601-2-26, IEC 60601-1-2, ISO 14971. Non-patient contact device.
Indications for Use
Indicated for use as a front-end amplifier to acquire, store, and transmit electrophysiological signals (EEG) in wired or wireless modes for the EMS Neurodiagnostic system in clinical, hospital, operating room, and epilepsy evaluation environments.
Regulatory Classification
Identification
A physiological signal amplifier is a general purpose device used to electrically amplify signals derived from various physiological sources (e.g., the electroencephalogram).
Predicate Devices
- Nicolet Wireless EEG Amplifier (K103140)
Reference Devices
- Nonin USA 8000 and 7000 series pulse oximeter sensors (K092101)
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue box, followed by the words "U.S. FOOD & DRUG" in blue, and the word "ADMINISTRATION" in a smaller font below.
October 6, 2017
EMS Handels Gesellschaft m.b.H. % Ms. Yolanda Smith Consultant Smith Associates 1468 Harwell Avenue Crofton, Maryland 21114
Re: K171397
Trade/Device Name: Sienna Ultimate Wireless Amplifier Regulation Number: 21 CFR 882.1835 Regulation Name: Physiological Signal Amplifier Regulatory Class: Class II Product Code: GWL, GWO Dated: September 6, 2017 Received: September 8, 2017
Dear Ms. Yolanda Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
{1}------------------------------------------------
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
William J. Heetderks -S 2017.10.06 17:00:34 -04'00'
for Carlos L. Peña. PhD. MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K171397
Device Name Sienna Ultimate EEG Amplifier
Indications for Use (Describe)
The Sienna Ultimate EEG amplifier is intended to be used as a front end amplifier to acquire, store and transmit electrophysiological signals in a wired or wireless mode for the EMS Neurodiagnostic system.
| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|
|X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
# 510(k) Summary
#### SPONSOR
| Company Name: | EMS Handels Gesellschaft m.b.H |
|-----------------|--------------------------------------------------|
| Company Address | 1 Jochingergasse<br>Korneuburg<br>Austria A-2100 |
| Telephone: | +43 2262 61655-0 |
| Fax: | +43 2262 61655-3 |
| Contact Person: | Ruzena Ortnerova |
Summary Preparation Date: April 10, 2017
### DEVICE NAME
| Trade Name: | Sienna Ultimate |
|----------------------|---------------------------------|
| Common/Usual Name: | EEG Amplifier |
| Classification Name: | Amplifier, Physiological Signal |
| Regulation Number: | 21 CFR 882.1400 |
| Product Code: | GWL, GWQ |
| Device Class: | Class II |
#### PREDICATE DEVICE
| Legally Marketed Equivalent Device | | |
|------------------------------------|--------------------------------|----------|
| Company | Product | 510(k) # |
| Carefusion 209, In. | Nicolet Wireless EEG Amplifier | K103140 |
#### DEVICE DESCRIPTION
The Sienna Ultimate is a small portable device which is capable of acquiring a variety of electrophysiological signals at variable sampling frequencies and can be used in a wide variety of EEG applications.
The proposed device consists of two models designated as the 32 channel and the 64 channel amplifier in a wireless or wired mode, passive headboxes, medical grade power supply, WLAN access point (for wireless models) or medical grade isolated LAN cable (for wired models), Sienna EEG software. The following accessories can be connected to the passive headboxes: EEG electrodes, EEG headcaps and pulse oximeter sensors. The accessories are not supplied by EMS. EMS recommends the use of FDA cleared EEG electrodes and EEG headcaps from local US suppliers. For use as a pulse oximeter
{4}------------------------------------------------
sensor, the FDA cleared reusable and disposable sensors (K092101, Nonin USA) from the 8000 and 7000 series are recommended.
In wireless models: WLAN access points collect the wireless data transmissions. The amplifiers are IP addressable and can be connected directly to a network device. In all situations the amplifiers store a copy of the data locally to allow for data backup. The amplifiers provide storage and subsequent transmission of data that is not transferred live when the amplifier is in out of range situations.
In wired models: Amplifiers can be connected via medical grade isolated LAN cable to the network. The amplifiers are IP addressable. The amplifiers store a copy of the data locally to allow for data backup. The amplifiers provide storage and subsequent transmission of data that is not transferred live when the amplifier is disconnected from the LAN interface.
The use of 2 pcs. of 64 channel amplifier models (wireless or wired mode) enables EEG acquisition of up to 128 channels.
## DEVICE INDICATIONS FOR USE
The Sienna Ultimate EEG amplifier is intended to be used as a front end amplifier to acquire, store and transmit electrophysiological signals in a wired or wireless mode for the EMS Neurodiagnostic system.
| Parameters | Subject Device | Predicate Device | Similarities and<br>Difference |
|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------|
| | EMS Biomedical | CareFusion 209 | |
| | Sienna ULTIMATE | Nicolet Wireless EEG<br>Amplifier | |
| 510(k) Number | | K103140 | |
| Product Code | GWL, GWQ | GWL, GWQ | Same |
| Regulation No. | 21 CFR 882.1400 | 21 CFR 882.1400 | Same |
| Regulation Name | Amplifier, Physiological | Amplifier, Physiological | Same |
| Indications for<br>Use Statement | The Sienna Ultimate Wireless<br>EEG amplifier is intended to<br>be used as a front end<br>amplifier to acquire, store<br>and transmit<br>electrophysiological signals in<br>a wired or wireless mode<br>for the EMS Neurodiagnostic<br>system. | The Nicolet Wireless EEG<br>Amplifier is intended to be<br>used as a front end amplifier<br>to acquire, store, and<br>transmit electrophysiological<br>signals in a wired or wireless<br>mode for the Nicolet<br>Neurodiagnostic system. | Same |
#### COMPARISON OF TECHNICAL CHARACTERISTICS 807.92(a)(6)
{5}------------------------------------------------
| Description of<br>Device | The Sienna Ultimate EEG Wireless<br>Amplifier is a small<br>portable device which is<br>capable of acquiring a<br>variety of<br>electrophysiological<br>signals at variable<br>sampling frequencies and<br>can be used in a wide<br>variety of EEG<br>applications. The amplifier<br>has wireless capability and<br>an optional feature of<br>pulse oximetry is available. | The Nicolet EEG Wireless<br>Amplifier is a small<br>portable device which is<br>capable of acquiring a<br>variety of<br>electrophysiological<br>signals at variable<br>sampling frequencies and<br>can be used in a wide<br>variety of EEG<br>applications. The amplifier<br>has wireless capability and<br>an optional feature of<br>pulse oximetry is available. | Same |
|----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Clinical<br>Application<br>Environment | For use in research<br>institutions, clinics,<br>hospital, operating room<br>and epilepsy evaluation<br>environments. | For use in research<br>institutions, clinic,<br>hospital, operating room<br>and epilepsy evaluation<br>environments. | Same. |
| Intended User | A healthcare professional<br>who has the training and<br>knowledge to undertake EEG<br>examinations and is familiar<br>with EEG<br>equipment and practice. | A healthcare professional<br>who has the training and<br>knowledge to undertake EEG<br>examinations and is familiar<br>with EEG<br>equipment and practice. | Same |
| Channels | 32 EEG (all configurable as<br>bipolar) + SpO2 + patient<br>event button. | 32 EEG (8 configurable as<br>bipolar) + SpO2 + patient<br>event button. | Same |
| ADC Resolution | 16 bits (16 bits software) | 24 bits (16 bits software) | Different<br>Sienna Ultimate uses a 16<br>bits analog digital<br>convertor in SAR<br>technology<br><br>Nicolet Wireless EEG<br>amplifier (K103140) uses<br>24 bit analog digital<br>convertor, SD technology.<br><br>Using the SAR<br>technology, EMS EEG<br>amplifier delivers more<br>precise results.<br>The difference does not<br>affect adversely safety<br>and effectiveness. |
| Full Scale Input | ±5 mV | ± 5 mV | Same |
| Sampling Rate | 256-4000 Hz | 125 - 12000 Hz | Different<br>Sienna Ultimate uses<br>ADC's in SAR technology<br>and the predicate device<br>uses ADC's in SD<br>technology<br><br>The result is the same<br>and the difference in<br>sampling rate range does<br>not adversely affect<br>safety and effectiveness. |
| Input Impedance | >100 ΜΩ | > 40 ΜΩ | Different<br>The quality of the signal is<br>depending on the input<br>impedance. The higher<br>the input impedance, the<br>more accurate is the<br>signal quality.<br><br>The better signal quality<br>positively affects the<br>device effectiveness and<br>does not adversely affect |
| CMRR | > 110dB at 50-60Hz | > 110dB at 50-60Hz | Same |
| Input Noise | < 2.0 µV pk-pk | < 2.0 µV pk-pk | Same |
| Bandwidth (-3dB) | 0,1-1500 Hz max. | 0.048 to 5856 Hz max. | Different<br>Range is sufficient for EEG<br>examinations, does not<br>adversely affect safety<br>and effectiveness. |
| Input Bias Current | < 200 pA | < 200 pA | Same |
| Calibration | 100 µV at 1 sec period | 10, 50, 100, 1000 µV at 1, 5,<br>10, 20 sec period | Different<br>EMS uses 100 µV square<br>wave 1Hz calibration<br>signal, because this signal<br>is commonly used in EEG<br>acquisition.<br>Using this commonly<br>used 100 µV at 1 sec<br>signal, the experienced<br>user quickly can identify<br>the filter characteristics. |
| Impedance<br>Pass/Fail Levels | 1-50 kΩ<br>Linear measurement on all<br>channels, user definable<br>steps from the above range. | 2, 5, 10, 20, 50 kΩ | Substantially equivalent<br>to Nicolet Wireless EEG<br>amplifier (K103140),<br>more flexible — user<br>definable steps from the<br>range |
| Host PC | Wired (Ethernet) or | Wired (Ethernet) or | Same |
| Communication | Wireless (802.11b/g) | Wireless (802.11b/g) | Same |
| Power | Battery or medical grade<br>power supply | Battery or medical grade<br>power supply | Same |
| Internal Storage | 32 GB flash card | 32 GB flash card | Same |
| Internal Battery | Li-ion rechargeable | Li-ion rechargeable | Same |
| Patient Event | Yes | Yes | Same |
| Patient Contact | Device does not directly<br>contact the patient | Device does not directly<br>contact the patient | Same |
| Size | 13 x 7,2 x 4 cm | 13 x 16 x 7 cm | Smaller size, more<br>comfortable for patient,<br>does not adversely affect<br>safety and effectiveness. |
| Weight | 230 gm | 725 gm | Smaller weight, more<br>comfortable for patient,<br>does not adversely affect<br>safety and effectiveness. |
| Compliance/<br>regulatory | EN60601-1<br>EN60601-2-26<br>EN60601-1-2<br>CE Mark | IEC 60601-1 + ANSI + CAN<br>IEC 60601-2-26<br>IEC 60601-1-2<br>CE Mark | Substantially equivalent<br>to the Nicolet Wireless<br>EEG amplifier (K103140). |
{6}------------------------------------------------
{7}------------------------------------------------
The Sienna Ultimate EEG amplifier has the same indication for use, clinical application environment, same intended users and substantially same features as the predicate device Nicolet Wireless EEG amplifier (K103140). The differences between the subject device and the predicate device are:
{8}------------------------------------------------
- ADC resolution. Sienna Ultimate uses a 16 bits analog digital convertor in SAR . technology, which causes no delay between input and output. Sienna Ultimate uses the full 16 bit of the ADC by software. Nicolet Wireless EEG amplifier (K103140) uses 24 bit analog digital convertor, SD technology, which causes delay between input and output. When using this technology, high oversampling is needed to minimize the delay. Nicolet Wireless EEG amplifier uses only the first 16 bit from the analog digital convertor by the software - same resolution to Sienna Ultimate. Using the SAR technology, EMS EEG amplifier delivers more precise results. The subject and predicate devices both finally transfer and store the data in software with 16 bits. The safety is not adversely affected by this feature. The efficacy is positively influenced in the new device.
- . Sampling rate - The difference in sampling rate between the subject device and the predicate device is caused by the different ADC technologies which are used. The predicate device uses the ADC (analog digital convertor) SD (sigma delta) technology which requires a very high oversampling to minimize the delay of final output sampling rate. The subject device, Sienna Ultimate uses the ADC´s in SAR technology which does not require oversampling up to 12000 Hz. Therefore, the sampling rate from 256-4000Hz is fully sufficient.
- Input impedance - The quality of the signal is depending on the input impedance. The higher the input impedance, the more accurate is the signal quality. The Sienna Ultimate uses higher input impedance. The safety is not adversely affected by higher impedance values.
- . Bandwidth - The range from 0,1 up to 1500 Hz is sufficient for EEG examinations. Typical EEG spectrum ranges from 0.1 Hz up to 100 Hz. Therefore, the difference in bandwidth up to 1500 Hz and up to 5856 Hz does not influence the product effectiveness and the safety.
#### PERFORMANCE DATA
#### Safety Testing
| Test | Test description | Purpose | Results |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Basic safety test<br>IEC 60601-1:2012 ed.<br>3.1 | Medical electrical equipment - Part<br>1: General requirements for basic<br>safety and essential performance.<br>Following tests were performed:<br>4.11 power input<br>5.7 humidity preconditioning<br>5.9.2 determination of accessible<br>parts<br>7.1.2 legibility of marking<br>7.1.3 durability of marking<br>8.7 leakage currents<br>8.8.3 dielectric strength test<br>9.3 surfaces, corners and edges | This standard applies to<br>Medical electrical<br>equipment and to general<br>requirements for basic<br>safety and essential<br>performance of Medical<br>electrical equipment.<br>Test was performed on the<br>subject device to<br>demonstrate the compliance<br>with the requirements for<br>basic safety and essential<br>performance. | There were no deviations<br>from the standard and the<br>proposed device passed<br>the applicable tests and<br>standards. |
| | 11.1 excessive temperatures in<br>ME equipment<br>11.6.1 overflow, spillage, leakage,<br>ingress of water<br>13.2 abnormal operation<br>15.3 mechanical strength tests | | |
| EMC compatibility test<br>IEC 60601-1-2 :2014 | Medical electrical equipment - Part<br>1-2: general requirements for basic<br>safety and essential performance –<br>Collateral Standard:<br>Electromagnetic disturbances –<br>Requirements and tests.<br>Tests of EMC emission and<br>immunity were performed on the<br>subject device including the<br>accessories (see 2.2 of the test<br>report). | This standard applies to<br>Medical electrical<br>equipment and to general<br>requirements for basic<br>safety and essential<br>performance. It specifies the<br>Requirements and tests with<br>regard to Electromagnetic<br>disturbances.<br>Test was performed on the<br>subject device to<br>demonstrate the compliance<br>with the EMC standard and<br>to confirm the substantial<br>equivalence to the predicate<br>device. | There were no deviations<br>from the standard and<br>the sample of the<br>proposed device passed<br>the acceptance criteria of<br>the applicable tests and<br>requirements. |
| Usability<br>IEC 60601-1-6,<br>Edition 3.1 | Medical electrical equipment - Part<br>1-6: General requirements for basic<br>safety and essential performance -<br>Collateral standard: Usability | This standard specifies a<br>process for a manufacturer to<br>analyze, specify, design,<br>verify and validate usability,<br>as it relates to basic safety<br>and essential performance of<br>medical electrical<br>equipment. This usability<br>engineering process assesses<br>and mitigates risks caused by<br>usability problems<br>associated with correct use<br>and use errors, e.g., normal<br>use.<br>The test was performed on<br>the subject device to<br>demonstrate the compliance<br>with the usability<br>requirements standard. | There were no deviations<br>from the standard and<br>the proposed device<br>passed the applicable<br>tests and requirements. |
| Electroencephalographs<br>IEC 60601-2-26<br>Edition 3 | Medical electrical equipment - Part<br>2-26: Particular requirements for the<br>basic safety and essential<br>performance of<br>electroencephalographs | This standard applies to<br>basic safety and essential<br>performance of<br>electroencephalographs used<br>in a clinical environment<br>(e.g., hospital, physician's<br>office, etc.).<br>Test was performed on the<br>subject device to<br>demonstrate the compliance<br>with the basic safety and<br>essential performance of<br>electroencephalographs<br>standard and to determine<br>the substantial equivalence | There were no deviations<br>from the standard and<br>the proposed device<br>passed the applicable<br>tests and requirements. |
| Risk Management<br>ISO 14971:2012 | Medical devices. Application of<br>risk management to medical<br>devices | This standard specifies the<br>requirements with regard to<br>the application of risk<br>management to medical<br>devices.<br>The risk management was<br>conducted on the subject<br>device to demonstrate the<br>compliance with the standard. | The applied risk<br>management and the<br>evaluation of the risks<br>connected with the use of<br>the proposed device<br>demonstrate, that the<br>device complies with the<br>requirements of risk<br>management to medical<br>devices. |
| Biological<br>evaluation<br>ISO10993-1 | Biological evaluation of medical<br>devices – evaluation and testing<br>within the risk management<br>process | This standard specifies the<br>requirements to the biological<br>evaluation of medical devices.<br>Test was not applicable - the<br>subject device is non contact<br>device. | The proposed device is non<br>contact device, same as the<br>predicate device K103140 -<br>Nicolet Wireless EEG<br>Amplifier. |
| FCC Specific<br>Absorption Ratio<br>(SAR)<br>FCC Part 15C | FCC Specific Absorption Ratio<br>(SAR) | These are federal rules and<br>regulations regarding<br>unlicensed transmissions.<br>The data was leveraged by<br>review of manufacturer's<br>labeling information (datasheet<br>and user manual). | The proposed device passes<br>the applicable rules and<br>regulations. The compliance<br>with these regulations is<br>substantially equivalent to<br>the predicate device<br>K103140 - Nicolet Wireless<br>EEG Amplifier. |
| Radio Spectrum<br>tests<br>Wideband<br>transmission<br>systems; Data<br>transmission<br>equipment<br>operating in the 2.4<br>GHz ISM band and<br>using wide band<br>modulation<br>techniques - EN<br>300 328 | Following tests were performed:<br>RF output power, Power spectral<br>density, Duty Cycle, Medium<br>utilization factor, Occupied<br>channel bandwidth, Transmitter<br>unwanted emissions in the out-<br>of-band domain, transmitter<br>unwanted emissions in the<br>spurious domain, Receiver<br>spurious emission, Receiver<br>blocking | This harmonized standard<br>covers the essential<br>requirements on data<br>transmission equipment<br>operating in the 2.4 GHz ISM<br>band.<br>The tests were performed on<br>the subject device to<br>demonstrate the compliance<br>with the requirements of the<br>harmonized standard. | There were no deviations<br>from the standard and the<br>proposed device passed the<br>applicable tests and<br>requirements. |
| EMC tests<br>Electromagnetic<br>compatibility and<br>Radio Spectrum<br>matters (ERM) – EN<br>301 489-1 and EN<br>301 489-17 | Electromagnetic compatibility<br>tests, tests of EMC emission and<br>immunity, conducted emission,<br>radiated emission, limits and<br>requirements | This harmonized standard covers<br>the requirements on<br>electromagnetic compatibility and<br>Radio Spectrum matters | There were no<br>deviations from the<br>standard and the<br>proposed device<br>passed the<br>applicable tests and<br>requirements. |
| Battery safety tests<br>UN/DOT 38.3 | Transportation testing for lithium<br>batteries | The data was leveraged by review<br>of manufacturer´s labeling<br>information. | The proposed<br>device passed the<br>UN Transportation<br>tests T1-T8. |
{9}------------------------------------------------
{10}------------------------------------------------
{11}------------------------------------------------
# Summary Discussion of Bench Performance Data
The Sienna Ultimate amplifier passed all specified test requirements.
Testing confirmed that the device design and device performance meet the requirements of the standards listed in the above performance testing summary.
The a.m. standards address safety, particular safety for Electroencephalographs, biocompatibility, EMC compatibility, risks, usability, battery safety and radiated energy.
The safety, performance and effectiveness are substantially equivalent to the predicate device K103140 – Nicolet Wireless EEG Amplifier.
Clinical testing was not performed with this device.
#### CONCLUSION
The Sienna Ultimate EEG amplifier meets the functional claims and intended use as described in the product labeling. The safety and effectiveness are substantially equivalent to the predicate device, Nicolet Wireless EEG Amplifier.
